(Q34109294)

31 July 2017

1 reference

title

The clinical importance of conventional and quantitative liver function tests in liver transplantation (English)

1 reference

31 July 2017

main subject

liver transplantation

1 reference

E Tanaka

1

1 reference

31 July 2017

S Inomata

series ordinal

2

1 reference

31 July 2017

H Yasuhara

series ordinal

3

1 reference

31 July 2017

publication date

1 December 2000

1 reference

Journal of Clinical Pharmacy and Therapeutics

31 July 2017

published in

1 reference

31 July 2017

volume

25

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

411-419

1 reference

The use of lidocaine as a test of liver function in liver transplantation

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Lignocaine metabolite formation as a measure of pre-transplant liver function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Selection criteria for liver transplant donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Predictors of one-year pretransplant survival in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Relationship of apolipoproteins AI, B and lipoprotein Lp(a) to hepatic function of liver recipients during the early post-transplant period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Prognostic value of the monoethylglycinexylidide test in pediatric liver transplant candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

The use of the lidocaine-monoethylglycinexylidide test in the liver transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Prognostic value of the monoethylglycinexylidide liver function test in assessing donor liver suitability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

The lidocaine monoethylglycinexylidide test of liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Conventional and quantitative liver function tests after hepatic transplantation: a prospective long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Donor MEGX test fails to predict graft function after orthotopic liver transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Value of an extended monoethylglycinexylidide formation test and other dynamic liver function tests in liver transplant donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Value of the in vitro or in vivo monoethylglycinexylidide test for predicting liver graft function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Orthotopic liver transplantation with preservation of portocaval flow compared with venovenous bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Acute cyclosporine toxicity after liver transplantation is predicted by the lidocaine monoethylglycinexylidide test in the donor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Pharmacokinetic drug data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Galactose elimination capacity as a prognostic index in patients with fulminant liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Indocyanine green elimination test in orthotopic liver recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

The metabolism and excretion of trimethadione in patients with percutaneous transhepatic biliary drainage and renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00308.X

10.1046/J.1365-2710.2000.00308.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference